FDA Approves First Ever Vitiligo treatment
FDA approves a topical treatment to treat repigmentation in vitiligo in patients 12 and older Late Monday, the FDA gave the green light to Opzelura, Incyte’s sister JAK inhibitor Jakafi,…
FDA approves a topical treatment to treat repigmentation in vitiligo in patients 12 and older Late Monday, the FDA gave the green light to Opzelura, Incyte’s sister JAK inhibitor Jakafi,…